- Report
- February 2026
- 250 Pages
Global
From €4063EUR$4,490USD£3,471GBP
- Report
- July 2026
- 197 Pages
Global
From €5294EUR$5,850USD£4,522GBP
- Report
- July 2026
- 340 Pages
Global
From €5294EUR$5,850USD£4,522GBP
- Report
- July 2026
- 464 Pages
Global
From €5294EUR$5,850USD£4,522GBP
- Report
- July 2026
- 192 Pages
Global
From €5294EUR$5,850USD£4,522GBP
- Report
- December 2025
- 200 Pages
Global
From €7194EUR$7,950USD£6,145GBP
- Report
- May 2026
- 100 Pages
Global
From €2442EUR$2,699USD£2,086GBP
- Report
- May 2026
- 150 Pages
Global
From €2442EUR$2,699USD£2,086GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2524EUR$2,789USD£2,156GBP
- Report
- November 2025
- 160 Pages
Global
From €2859EUR$3,160USD£2,443GBP
€3574EUR$3,950USD£3,053GBP
- Report
- April 2026
- 160 Pages
Global
From €3004EUR$3,320USD£2,566GBP
€3755EUR$4,150USD£3,208GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3258EUR$3,600USD£2,783GBP
- Report
- September 2024
- 110 Pages
Global
From €5384EUR$5,950USD£4,599GBP
- Report
- July 2023
- 220 Pages
Global
From €1801EUR$1,990USD£1,538GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2253EUR$2,490USD£1,925GBP
- Report
- March 2025
- 200 Pages
Global
From €2253EUR$2,490USD£1,925GBP
- Report
- March 2024
- 200 Pages
Global
From €3755EUR$4,150USD£3,208GBP
- Report
- January 2024
- 200 Pages
Global
From €3755EUR$4,150USD£3,208GBP
- Report
- August 2023
- 145 Pages
Global
From €2850EUR$3,150USD£2,435GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2715EUR$3,000USD£2,319GBP

Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more